These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
580 related articles for article (PubMed ID: 9533462)
1. Sensitivity to sparfloxacin and other antibiotics, of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis strains isolated from adult patients with community-acquired lower respiratory tract infections: a European multicentre study. SPAR Study Group. Surveillance Programme of Antibiotic Resistance. Richard MP; Aguado AG; Mattina R; Marre R J Antimicrob Chemother; 1998 Feb; 41(2):207-14. PubMed ID: 9533462 [TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Canadian isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae to oral antimicrobial agents. Blondeau JM; Vaughan D; Laskowski R; Borsos S; Int J Antimicrob Agents; 2001 Jun; 17(6):457-64. PubMed ID: 11397615 [TBL] [Abstract][Full Text] [Related]
3. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China. Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692 [TBL] [Abstract][Full Text] [Related]
4. The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2003 and 2004. Melo-Cristino J; Santos L; Ramirez M; Rev Port Pneumol; 2006; 12(1):9-30. PubMed ID: 16572254 [TBL] [Abstract][Full Text] [Related]
5. The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. Felmingham D; Grüneberg RN J Antimicrob Chemother; 2000 Feb; 45(2):191-203. PubMed ID: 10660501 [TBL] [Abstract][Full Text] [Related]
6. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment. Pfaller MA; Ehrhardt AF; Jones RN Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437 [TBL] [Abstract][Full Text] [Related]
7. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN; J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398 [TBL] [Abstract][Full Text] [Related]
8. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998. Sahm DF; Jones ME; Hickey ML; Diakun DR; Mani SV; Thornsberry C J Antimicrob Chemother; 2000 Apr; 45(4):457-66. PubMed ID: 10747822 [TBL] [Abstract][Full Text] [Related]
9. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007]. Sun HL; Yang QW; Xu YC; Wang H; Xie XL; Chen MJ; Zhang XZ; Liu Y; Ye HF; Sun ZY; Duan Q; Ni YX; Yu YS; Zhao WS; He L; Wang J; Ji P; Liu PP; Zhang LX Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2983-7. PubMed ID: 20137709 [TBL] [Abstract][Full Text] [Related]
10. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000]. Melo-Cristino J; Fernandes ML; Serrano N; Acta Med Port; 2001; 14(5-6):459-68. PubMed ID: 11878155 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods. Morrissey I; Robbins M; Viljoen L; Brown DF J Antimicrob Chemother; 2005 Feb; 55(2):200-8. PubMed ID: 15649996 [TBL] [Abstract][Full Text] [Related]
12. Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin. Hoogkamp-Korstanje JA; Dirks-Go SI; Kabel P; Manson WL; Stobberingh EE; Vreede RW; Davies BI J Antimicrob Chemother; 1997 Mar; 39(3):411-4. PubMed ID: 9096192 [TBL] [Abstract][Full Text] [Related]
13. A multicenter study of the antimicrobial susceptibility of Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis isolated from patients with community-acquired lower respiratory tract infections in 1999 in Portugal. Melo-Cristino J; Fernandes ML; Serrano N; Microb Drug Resist; 2001; 7(1):33-8. PubMed ID: 11310801 [TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study Group. Ballow CH; Jones RN; Johnson DM; Deinhart JA; Schentag JJ Diagn Microbiol Infect Dis; 1997 Nov; 29(3):173-86. PubMed ID: 9401810 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98). Sader HS; Gales AC; Granacher TD; Pfaller MA; Jones RN; Braz J Infect Dis; 2000 Oct; 4(5):245-54. PubMed ID: 11063556 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance Programme. Reynolds R; Shackcloth J; Felmingham D; MacGowan A; J Antimicrob Chemother; 2003 Dec; 52(6):931-43. PubMed ID: 14585865 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China: Results from the CARTIPS Antimicrobial Surveillance Program. Zhang Y; Zhang F; Wang H; Zhao C; Wang Z; Cao B; Du Y; Feng X; Hu Y; Hu B; Ji P; Liu Z; Liu Y; Liao W; Lu J; Sun H; Wang Z; Xu X; Xu X; Yang Q; Yu Y; Zhang R; Zhuo C J Glob Antimicrob Resist; 2016 Jun; 5():36-41. PubMed ID: 27436464 [TBL] [Abstract][Full Text] [Related]
18. [Serotype distribution and drug resistance of Tian HL; Shi W; Zhou HF; Yuan L; Yao KH; Rexiati D; Xu AM Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):279-283. PubMed ID: 29614568 [No Abstract] [Full Text] [Related]
19. Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values. Jones RN; Fritsche TR; Sader HS; Stilwell MG Diagn Microbiol Infect Dis; 2007 May; 58(1):9-17. PubMed ID: 17408903 [TBL] [Abstract][Full Text] [Related]
20. Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group. Blondeau JM; Suter M; Borsos S J Antimicrob Chemother; 1999 Mar; 43 Suppl A():25-30. PubMed ID: 10225568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]